Cargando…
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
In June 2017, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, organized a workshop entitled “Pharmacokinetics-Pharmacodynamics (PK/PD) for Development of Therapeutics against Bacterial Pathogens.” The aims were to discuss details of various PK/PD...
Autores principales: | Bulitta, Jürgen B., Hope, William W., Eakin, Ann E., Guina, Tina, Tam, Vincent H., Louie, Arnold, Drusano, George L., Hoover, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496039/ https://www.ncbi.nlm.nih.gov/pubmed/30833428 http://dx.doi.org/10.1128/AAC.02307-18 |
Ejemplares similares
-
Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents
por: Rizk, M. L., et al.
Publicado: (2019) -
Sex-specific gene expression in preimplantation mouse embryos
por: Eakin, Guy S, et al.
Publicado: (2006) -
Oncogenic AKTivation of translation as a therapeutic target
por: Hsieh, A C, et al.
Publicado: (2011) -
Viewing Bacterial Colonization through the Lens of Systems Biology
por: Barron, Madeline R., et al.
Publicado: (2022) -
Robust and specific inhibition of microRNAs in Caenorhabditis elegans
por: Kundu, Samrat T, et al.
Publicado: (2010)